Skip to Content

CL 23 (Fenofibrate (Micronized) 134 mg)

Pill with imprint CL 23 is Yellow & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 134 mg. It is supplied by Alvogen, Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CL 23

Fenofibrate (Micronized)

Imprint:
CL 23
Strength:
134 mg
Color:
Yellow & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Alvogen, Inc.
National Drug Code (NDC):
47781-0519

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide